{
    "summary": "The bill, the Interagency Patent Coordination and Improvement Act of 2025, aims to establish an interagency task force between the United States Patent and Trademark Office (USPTO) and the Food and Drug Administration (FDA). This task force will facilitate information sharing, technical assistance, and collaboration regarding patents for human drugs and biological products. The goal is to improve the accuracy and efficiency of patent examination and ensure consistent representation of information across federal agencies. The bill mandates a report on the task force's activities and outlines protocols for handling confidential information.",
    "tags": [
        "Technology regulation",
        "Healthcare",
        "Federal agency action",
        "Consumer protection",
        "Transparency"
    ],
    "category": "Healthcare & Public Health"
}